Chemokine release from human rhinovirus–infected airway epithelial cells promotes fibroblast migration

Journal of Allergy and Clinical Immunology

Volumn 138, Issue 1, 2016, Pages 114-122.e4

  Shelfoon, Christopher ^a   Shariff, Sami ^a   Traves, Suzanne L ^a   Kooi, Cora ^a   Leigh, Richard ^a   Proud, David ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Airway epithelium; airway remodeling; chemoattractants; fibroblasts; human rhinovirus; inflammation; migration

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CXCR1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; NAVARIXIN; NEUTRALIZING ANTIBODY; PERTUSSIS TOXIN; RANTES; SCH 546738; UNCLASSIFIED DRUG; CONDITIONED MEDIUM;

AIRWAY EPITHELIAL CELL; ARTICLE; ASTHMA; CELL MIGRATION; CONCENTRATION RESPONSE; CONDITIONED MEDIUM; DISEASE COURSE; FIBROBLAST; FIBROBLAST CULTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN RHINOVIRUS; HUMAN RHINOVIRUS A16; HUMAN TISSUE; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; RETICULAR LAMINA; RHINOVIRUS INFECTION; RISK FACTOR; VIRUS REPLICATION; WHEEZING; CELL LINE; CELL MOTION; DRUG EFFECTS; EPITHELIUM CELL; METABOLISM; PHYSIOLOGY; PICORNAVIRUS INFECTION; RESPIRATORY MUCOSA; RHINOVIRUS; SECRETION (PROCESS); VIROLOGY;

CELL LINE; CELL MOVEMENT; CHEMOKINES; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; PICORNAVIRIDAE INFECTIONS; PRIMARY CELL CULTURE; RESPIRATORY MUCOSA; RHINOVIRUS;

EID: 84957646872     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.12.1308     Document Type: Article

References (31)

1. 1 Jeffery, P.K., Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 1 (2004), 176–183.
2. 2 James, A.L., Wenzel, S., Clinical relevance of airway remodelling in airway diseases. Eur Respir J 30 (2007), 134–155.
3. 3 Paré, P.D., McParland, B.E., Seow, C.Y., Structural basis for exaggerated airway narrowing. Can J Physiol Pharmacol 85 (2007), 653–658.
4. 4 Sears, M.R., Greene, J.M., Willan, A.R., Wiecek, E.M., Taylor, D.R., Flannery, E.M., et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 349 (2003), 1414–1422.
5. 5 Pohunek, P., Warner, J.O., Turzíková, J., Kudrmann, J., Roche, W.R., Markers of eosinophilic inflammation and tissue re-modelling in children before clinically diagnosed bronchial asthma. Pediatr Allergy Immunol 16 (2005), 43–51.
6. 6 Saglani, S., Payne, D.N., Zhu, J., Nicholson, A.G., Bush, A., Jeffery, P.K., Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med 176 (2007), 858–864.
7. 7 O'Reilly, R., Ullmann, N., Irving, S., Bossley, C.J., Sonnappa, S., Zhu, J., et al. Increased airway smooth muscle in preschool wheezers who have asthma at school age. J Allergy Clin Immunol 131 (2013), 1024–1032.
8. 8 Saglani, S., Malmström, K., Pelkonen, A.S., Mamberg, P., Lindahl, H., Kajosaari, M., et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 171 (2005), 722–727.
9. 9 Lemanske, R.F. Jr., Jackson, D.J., Gangnon, R.E., Evans, M.D., Li, Z., Shult, P.A., et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 116 (2005), 571–577.
10. 10 Kotaniemi-Syrjänen, A., Vainionpää, R., Reijonen, T.M., Waris, M., Korhonen, K., Korppi, M., Rhinovirus-induced wheezing in infancy-the first sign of childhood asthma?. J Allergy Clin Immunol 111 (2003), 66–71.
11. 11 Jackson, D.J., Gangnon, R.E., Evans, M.D., Roberg, K.A., Anderson, E.L., Pappas, T.E., et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 178 (2008), 667–672.
12. 12 Winther, B., Hayden, F.G., Hendley, J.O., Picornavirus infection in children diagnosed by RT-PCR during longitudinal surveillance with weekly sampling: association with symptomatic illness and effect of season. J Med Virol 78 (2006), 644–650.
13. 13 Jartti, T., Lee, W.-M., Pappas, T., Evans, M., Lemanske, R.F. Jr., Gern, J.E., Serial viral infections in infants with recurrent respiratory illnesses. Eur Respir J 32 (2008), 314–320.
14. 14 Al-Muhsen, S., Johnson, J.R., Hamid, Q., Remodeling in asthma. J Allergy Clin Immunol 128 (2011), 451–462.
15. 15 Churchill, L., Chilton, F.H., Resau, J.H., Bascom, R., Hubbard, W.C., Proud, D., Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. Am Rev Respir Dis 140 (1989), 449–459.
16. 16 Sanders, S.P., Siekierski, E.S., Porter, J.D., Richards, S.M., Proud, D., Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol 72 (1998), 934–942.
17. 17 Subauste, M.C., Jacoby, D.B., Richards, S.M., Proud, D., Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 96 (1995), 549–557.
18. 18 Liu, Y., Shi, G., Role of G protein-coupled receptors in control of dendritic cell migration. Biomed Res Int, 2014, 2014, 738253.
19. 19 Leigh, R., Oyelusi, W., Wiehler, S., Koetzler, R., Zaheer, R.S., Newton, R., et al. Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. J Allergy Clin Immunol 121 (2008), 1238–1245.
20. 20 Psarras, S., Volonaki, E., Skevaki, C.L., Xatzipsalti, M., Bossios, A., Pratsinis, H., et al. Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinovirus. J Allergy Clin Immunol 117 (2006), 291–297.
21. 21 Proud, D., Leigh, R., Epithelial cells and airway diseases. Immunol Rev 242 (2011), 186–204.
22. 22 Tomankova, T., Kriegova, E., Liu, M., Chemokine receptors and their therapeutic opportunities in diseased lung: far beyond leukocyte trafficking. Am J Physiol Lung Cell Mol Biol 308 (2015), L603–L618.
23. 23 Puxeddu, I., Bader, R., Piliponsky, A.M., Reich, R., Levi-Schaffer, F., Berkman, N., The CC chemokine eotaxin/CCL11 had a selective profibrogenic effect on human lung fibroblasts. J Allergy Clin Immunol 117 (2006), 103–110.
24. 24 Tager, A.M., Kradin, R.L., LaCamera, P., Bercury, S.D., Campanella, G.S., Leary, C.P., et al. Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. Am J Respir Cell Mol Biol 31 (2004), 395–404.
25. 25 Barnes, J.C., Lumsden, R.V., Worrell, J., Counihan, I.P., O'Beirne, S.L., Belperio, J.A., et al. CXCR3 requirement for the interleukin-13-mediated up-regulation of interleukin-13Rα2 in pulmonary fibroblasts. Am J Respir Cell Mol Biol 53 (2015), 217–225.
26. 26 Jenh, C.-H., Cox, M.A., Cui, L., Reich, E.-P., Sullivan, L., Chen, S.-C., et al. A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection. BMC Immunol, 13, 2012, 2.
27. 27 Chapman, R.W., Minnicozzi, M., Celly, C.S., Phillips, J.E., Kung, T.T., Hipkin, R.W., et al. A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation. J Pharmacol Exp Ther 322 (2007), 486–493.
28. 28 Spurrell, J.C.L., Wiehler, S., Zaheer, R.S., Sanders, S.P., Proud, D., Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 289 (2005), L85–L95.
29. 29 Wang, X., Lau, C., Wiehler, S., Pow, A., Mazzulli, T., Gutierrez, C., et al. Syk is downstream of intercellular adhesion molecule-1 and mediates human rhinovirus activation of p38 MAPK in airway epithelial cells. J Immunol 177 (2006), 6859–6870.
30. 30 Leigh, R., Proud, D., Virus-induced modulation of lower airway diseases: pathogenesis and pharmacologic approaches to treatment. Pharmacol Ther 148 (2015), 185–198.
31. 31 Nie, L., Liu, Z.J., Zhou, W.X., Xiang, R.L., Xiao, Y., Lu, B., et al. Chemokine receptor CXCR3 is important for lung tissue damage and airway remodeling induced by short-term exposure to cigarette smoking in mice. Acta Pharmacol Sin 31 (2010), 436–442.